NanoGroup S.A. (NNG.WA)

PLN 2.37

(-1.25%)

Net Income Summary of NanoGroup S.A.

  • NanoGroup S.A.'s latest annual net income in 2023 was -7.88 Million PLN , down -922.61% from previous year.
  • NanoGroup S.A.'s latest quarterly net income in 2024 Q2 was -1.35 Million PLN , down -5.21% from previous quarter.
  • NanoGroup S.A. reported an annual net income of -771.54 Thousand PLN in 2022, up 92.78% from previous year.
  • NanoGroup S.A. reported an annual net income of -10.68 Million PLN in 2021, down -101.19% from previous year.
  • NanoGroup S.A. reported a quarterly net income of -1.28 Million PLN for 2024 Q1, up 57.38% from previous quarter.
  • NanoGroup S.A. reported a quarterly net income of -1.45 Million PLN for 2023 Q3, up 8.49% from previous quarter.

Annual Net Income Chart of NanoGroup S.A. (2023 - 2015)

Historical Annual Net Income of NanoGroup S.A. (2023 - 2015)

Year Net Income Net Income Growth
2023 -7.88 Million PLN -922.61%
2022 -771.54 Thousand PLN 92.78%
2021 -10.68 Million PLN -101.19%
2020 -5.3 Million PLN -240.01%
2019 -1.56 Million PLN 33.39%
2018 -2.34 Million PLN -16.45%
2017 -2.01 Million PLN -156.11%
2016 -786.14 Thousand PLN -9.77%
2015 -716.17 Thousand PLN 0.0%

Peer Net Income Comparison of NanoGroup S.A.

Name Net Income Net Income Difference
Bioceltix S.A. -13.68 Million PLN 42.358%
BIOTON S.A. 2.27 Million PLN 446.805%
Captor Therapeutics Spolka Akcyjna -70.58 Million PLN 88.822%
Mabion S.A. 41.26 Million PLN 119.118%
Molecure S.A. -18.3 Million PLN 56.906%
Pharmena S.A. 28.94 Million PLN 127.262%
Poltreg S.A. -13.55 Million PLN 41.777%
Pure Biologics Spólka Akcyjna -35.69 Million PLN 77.896%
Ryvu Therapeutics S.A. -92.11 Million PLN 91.435%
Synthaverse S.A. 4.75 Million PLN 265.822%
Urteste S.A. -5.58 Million PLN -41.243%